XpresSpa Appoints Doctor Lewis Lipsey as First Chief Medical Director for Its XpresTest Subsidiary
14 April 2020 - 12:06AM
XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”),
a health and wellness company, announced today that Lewis Lipsey,
MD, has joined the Company as Chief Medical Director of its
XpresTest subsidiary, effective immediately. Doctor Lipsey’s role,
which is a new position at XpresSpa, will include working alongside
healthcare officials to help design safe and compliant protocols,
as well as train employees on COVID-19 testing.
Since March 19, 2020, XpresSpa has been in
advanced discussions with healthcare partners to develop a model
for COVID-19 screening and testing in U.S. airports and has created
the XpresTest, a wholly-owned subsidiary of XpresSpa Group, Inc, to
administer such screening and testing capabilities.
Doug Satzman, XpresSpa Group CEO, stated, "We
are thrilled to be adding Doctor Lipsey to our executive management
team. He has over 30 years of experience as a medical doctor and is
uniquely qualified to oversee Novel Coronavirus (COVID-19)
Screening and Testing at U.S. Airports. He will be a valued asset
and advisor to the Company during these unprecedented times.”
Mr. Satzman concluded, “We continue to make
progress with our public and private relationships to make COVID-19
screening and testing in U.S. airports a reality. We are targeting
to begin pilot testing at JFK airport for all airline employees,
contractors and workers, concessionaires and their employees, TSA
agents, and U.S. Customs and Border Protection agents. We believe
XpresSpa, through its XpresTest subsidiary, has a significant role
to play in the fight against COVID-19 within the travel sector
given our airport relationships, infrastructure, workforce with TSA
clearance and strong desire to keep travelers and those who work in
the airline industries safe.”
Dr. Lewis Lipsey is a highly regarded Medical
Doctor with over three decades of experience at high profile
hospitals. For the last 25 years, he has been in practice,
specializing in Hematology and Oncology. In addition, he also
served as a director of Hematology and Oncology at Martha’s
Vineyard Hospital. Dr. Lipsey is currently an attending physician
at several hospitals in New York City, including The Mount Sinai
Hospital, Mount Sinai Beth Israel and Lenox Hill Hospital. He is on
the voluntary teaching faculty of Icahn School of Medicine as well
as Northwell Health-Lenox Hill Hospital. He completed a fellowship
in Hematology at the University of California San Francisco and a
fellowship in Medical Oncology at the Dana-Farber Cancer Institute
in Boston, MA where he was an instructor at Harvard Medical School.
He was a medical resident at Brigham and Women’s Hospital, Harvard
Medical School, in Boston. MA and was the Chief Resident in
Internal Medicine at the VA Medical Center in West Roxbury, MA.
Dr. Lipsey received his undergraduate degree
from Brown University and his Medical Degree from Yale
University.
Dr. Lipsey added, "I am thrilled and honored to
be joining XpresSpa at such a critical time and look forward to
helping airport employees as we make COVID-19 screening more
accessible in U.S. Airports across the country. Our overall goal is
to assure a safer work and travel experience for flight industry
employees and passengers alike as we confront the new ‘normal’ in
the world around us.”
About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a health
and wellness holding company. XpresSpa Group’s core asset,
XpresSpa, is a leading airport retailer of spa services and related
health and wellness products, with 51 locations in 25 airports
globally. XpresSpa offers services that are tailored specifically
to the busy travel customer. XpresSpa is committed to providing
exceptional customer experiences with its innovative premium spa
services, as well as luxury travel products and accessories.
XpresSpa provides almost one million services to customers per year
at its locations in the United States, Netherlands, and the United
Arab Emirates. To learn more about XpresSpa Group, visit:
www.XpresSpaGroup.com. To learn more about XpresSpa, visit
www.XpresSpa.com.
Forward-Looking StatementsThis
press release may contain "forward-looking" statements within the
meaning of Section 27A of the Securities Act of 1933, and Section
21E of the Securities Exchange Act of 1934. These include
statements preceded by, followed by or that otherwise include the
words "believes," "expects," "anticipates," "estimates,"
"projects," "intends," "should," "seeks," "future," "continue," or
the negative of such terms, or other comparable terminology.
Forward-looking statements relating to expectations about future
results or events are based upon information available to XpresSpa
Group as of today's date and are not guarantees of the future
performance of the company, and actual results may vary materially
from the results and expectations discussed. Additional information
concerning these and other risks is contained in XpresSpa Group’s
most recently filed Annual Report on Form 10-K, Quarterly Report on
Form 10-Q, recent Current Reports on Form 8-K and other Securities
and Exchange Commission filings. All subsequent written and oral
forward-looking statements concerning XpresSpa Group, or other
matters and attributable to XpresSpa Group or any person acting on
its behalf are expressly qualified in their entirety by the
cautionary statements above. XpresSpa Group does not undertake any
obligation to publicly update any of these forward-looking
statements to reflect events or circumstances that may arise after
the date hereof.
Investor Relations:ICRRaphael
Gross(203) 682-8253
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Apr 2024 to May 2024
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From May 2023 to May 2024